Children’s National Hospital in Washington, D.C., is ending its practice of prescribing gender-affirming medications starting August 30. The move follows legal pressure from the Department of Justice and signals a broader shift across U.S. hospitals facing scrutiny over transgender treatments for minors.
Key Facts:
- Children’s National Hospital will stop prescribing gender-affirming medications as of August 30 due to legal and regulatory risks.
- The Justice Department issued over 20 subpoenas to providers of transgender procedures for minors in early July.
- The hospital does not perform gender-transition surgeries on minors and requires parental consent for hormone treatments.
- Other hospitals, including Children’s Hospital Los Angeles and Rush Medical Center in Chicago, are also ending similar programs.
- President Trump issued an executive order in January calling these procedures “mutilation” and vowed to end federal support for them.
The Rest of The Story:
Children’s National Hospital announced on its website that it will no longer prescribe gender-affirming medications starting August 30, citing “escalating legal and regulatory risks.”
While the hospital reassured families that mental health services remain available, it declined to confirm whether it had received a subpoena from the Department of Justice, which has begun investigating possible fraud and misconduct in pediatric transgender procedures.
This change follows a broader trend, with institutions like Children’s Hospital Los Angeles and Rush Medical Center in Chicago also halting gender-related treatments.
These actions come after President Donald Trump’s executive order declaring that such procedures “must end” and pledging to stop federal involvement.
A report from the Department of Health and Human Services also raised serious concerns about the safety and effectiveness of these treatments.
🔥🚨 BREAKING: Children's National Hospital in DC to end gender transition medical interventions, citing 'escalating legal and regulatory risks' as Justice Department investigates pediatric transgender procedures. pic.twitter.com/0ztusVnTeb
— Gays Against Groomers (@againstgrmrs) July 21, 2025
Commentary:
This decision is overdue. For too long, parts of the medical industry pushed experimental hormone treatments and irreversible surgeries on children without long-term data, relying on ideology over science.
Vulnerable kids were placed on a medical path that could lead to sterility, loss of sexual function, and lifelong regret—all in the name of affirmation.
The idea that a child—who can’t legally drive, vote, or get a tattoo—could undergo permanent physical changes with adult encouragement is unconscionable.
Parents were often pressured into silence or compliance, and medical professionals abandoned their duty to do no harm. That institutions are now retreating from these practices shows common sense is finally returning.
Trump’s executive order, while controversial, forced a national discussion that institutions could no longer ignore.
It’s encouraging to see state-level and now federal scrutiny on this issue. Restoring boundaries in pediatric care isn’t bigotry—it’s basic decency.
The Bottom Line:
Children’s National and other hospitals are stepping back from transgender treatments for minors under mounting legal and political pressure.
This shift reflects a broader reckoning with the unproven and often harmful nature of these medical interventions.
With courts upholding state bans and federal scrutiny growing, the tide is turning toward protecting vulnerable children from irreversible decisions.
The return to caution in medicine is not a regression—it’s a safeguard long overdue.
Read Next
– House Republicans Call For Arrests After ‘Russiagate’ Revelations
– Trump May Withhold Approval of New Stadium if Washington Team Doesn’t Change Name Back to ‘Redskins’
– Why The ‘Made in America’ Label May Be More of a Marketing Tool Than Truthful Advertising
– Defense Department Reshapes Two Centuries of Tradition With Pick To Lead U.S Naval Academy